Frontlight ResearchEarly access
CompletedNo phase
Point of Care Evaluation of Fibrinolysis in Sepsis
Key facts
- Who runs it
- Policlinico Hospital
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 100 people enrolled
- Started
- 22 Jan 2024
- Ended
- 30 Nov 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Clot Pro
- Record updated
- 8 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- age > 18 years
- sepsis or septic shock
- vasopressors required to maintain a MAP ≥ 65 mmHg despite adequate fluid resuscitation
Who cannot take part
- ECMO therapy
- use of oral anticoagulant drugs
- coagulation disorders
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Impaired fibrinolysis in septic patients is associated with worse outcome. The present study investigates fibrinolysis shutdown in septic patients, defined as prolonged ClotPro® TPA lysis time at 30 minutes. The TPA lysis time reference range is established in a cohort of healthy volunteers.
The 2 groups in the trial
- Septic patientsOther group
Treatment: Clot Pro
- Healthy volunteersOther group
Treatment: Clot Pro
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 8 April 2026